Apolipoprotein E knockout mice over-expressing human tissue inhibitor of metalloproteinase 1 are protected against aneurysm formation but not against atherosclerotic plaque development

Journal of Vascular Research

Volumn 43, Issue 6, 2006, Pages 493-501

  Cuaz Pérolin, Clarisse ^a,b   Jguirim, Imen ^d   Larigauderie, Guilhem ^a,b   Jlassi, Awatef ^d   Furman, Christophe ^a,b   Moreau, Martine ^c   Chapman, M John ^c   Fruchart, Jean Charles ^a,b   Slimane, Mohamed Naceur ^d   Mezdour, Hafid ^a   Rouis, Mustapha ^a,b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIV LILLE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Aneurysm; Atherosclerotic lesions; Metalloproteinase inhibitors; Plaque

Indexed keywords

APOLIPOPROTEIN E; COLLAGEN; DNA; ELASTIN; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LESION; ARTICLE; ATHEROSCLEROTIC PLAQUE; COLLAGEN DEGRADATION; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; ENZYME BLOOD LEVEL; FALSE ANEURYSM; FEMALE; HISTOLOGY; IMMUNOHISTOLOGY; LIPID DIET; MACROPHAGE; MALE; MICROANEURYSM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; UPREGULATION;

EID: 33750609508     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095309     Document Type: Article

References (25)

1. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126.
2. Halloran BG, Baxter BT: Pathogenesis of aneurysms. Semin Vasc Surg 1995;8:85-92.
3. Patel MI, Hardman DT, Fisher CM, Appleberg M: Current views on the pathogenesis of abdominal aortic aneurysms. J Am Coll Surg 1995;181:371-382.
4. Shah PK: Pathophysiology of plaque rupture and the concept of plaque stabilization. Cardiol Clin 1996;14:17-29.
5. Falk E: Plaque fissuring. The cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1983;50:127-134.
6. Dollery CM, McEwan JR, Henny AM: Matrix metalloproteinases and cardiovascular disease. Cir Res 1995;77:863-868.
7. DeClerck YA, Szpirer C, Aly M, Cassiman J, Eeckhout Y, Rousseau GG: The gene for tissue inhibitor of metalloproteinase-2 is localized on human chromosome 17q25. Genomics 1992;14:782-784.
8. Apte SS, Mattei MG, Olsen BR: Cloning of the cDNA encoding human tissue inhibitor of metalloproteinase-3 (TIMP-3) and mapping of the TIMP-3 gene to chromosome 22. Genomics 1994;19:293-297.
9. Willard HF, Durfy SJ, Mahtan MM, Dorkins H, Davized KE, Williams BRG: Regional localization of the TIMP gene on the human X chromosome. Hum Genet 1989;81:234-238.
10. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE: Molecular cloning and characterization of human tissue inhibitor of metalloproteinase-4. J Biol Chem 1996;271:30375-30380.
11. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-353.
12. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-140.
13. Silence J, Lupu F, Collen D, Lijnen HR: Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol 2001;21:1440-1445.
14. Johnson JL, George SJ, Newby AC, Jackson CL: Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci USA 2005;102:15575-15580.
15. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries E, Henney A: Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996;271:13055-13060.
16. Lemaitre V, O'Byrne TK, Borczuk AC, Okada Y, Tall AR, D'Armiento J: ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest 2001;107:1227-1234.
17. Lemaitre V, Soloway PD, D'Armiento J: Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1. Circulation 2003;107:333-338.
18. Silence J, Collen D, Lijnen HR: Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res 2002;90:897-903.
19. Rouis M, Adamy C, Duverger N, Lesnik P, Horellou P, Moreau M, Emmanuel F, Caillaud JM, Laplaud PM, Dachet C, Chapman MJ: Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation 1999;100:533-540.
20. Allaire E, Forough R, Clowes M, Starcher B, Clowes AW: Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 1998;102:1413-1420.
21. Griendling KK, Alexander RW: Endothelial control of the cardiovascular system: recent advances. FASEB J 1996;10:283-292.
22. Frydman J, Tomaro ML, Frydman RB: An analysis of the topography of molecular forms 1 and 3 of rat liver biliverdin reductase using polyclonal antibodies. Biochim Biophys Acta 1991;1076:321-329.
23. Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002;90:251-262.
24. Mamo JC, Elsegood CL, Gennat HC, Yu K: Degradation of chylomicron remnants by macrophages occurs via phagocytosis. Biochemistry 1996;35:10210-10214.
25. Luttun A, Lutgens E, Manderveld A, Maris K, Collen D, Carmeliet P, Moons L: Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 2004;109:1408-1414.